BKYI

Bio-Key Intl Inc

• TipRanks·07/07 13:31

  BIO-key International Trading Reinstated on Nasdaq Capital Market

• TipRanks·07/07 12:06

  BIO-key regains compliance with Nasdaq

• TipRanks·06/10 22:49

  BIO-key Faces Heightened Nasdaq Delisting and Compliance Risks

• Seeking Alpha·06/10 21:10

  BIO-key International faces Nasdaq notice for missing Q1 10-Q filing deadline

• TipRanks·06/10 21:05

  BIO-key receives noncompliance notification from Nasdaq

• TipRanks·05/20 06:30

  Bio-Key International Signals Turn Toward Profitability

• TipRanks·05/18 23:29

  BIO-key International Delays Quarterly SEC Filing

• Seeking Alpha·05/18 16:42

  BIO-key signals scaling revenue toward $5M-$10M quarterly as it expects Q2 profitability

• Seeking Alpha·05/18 12:07

  BIO-key GAAP EPS of -$0.15, revenue of $2.15M misses by $0.05M

• Dow Jones·05/18 12:00

  *BIO-key 1Q Loss/Shr 15c >BKYI

• Dow Jones·05/18 12:00

  *BIO-key 1Q Rev $2.15M >BKYI

• TipRanks·05/12 22:41

  BIO-key Faces Nasdaq Delisting, Shifts Trading to OTC

• TipRanks·05/12 22:36

  BIO-key shares to move to OTC following Nasdaq suspension

• PUBT·05/12 20:46

  BIO-key shares move to OTC Markets May 13 after Nasdaq trading suspension

• TipRanks·05/12 20:45

  Biokey International trading resumes